Synthetic cannabinoids use in a sample of opioid-use disorder patients.
Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Farré M, Torrens M.
Alías-Ferri M, et al. Among authors: pacifici r.
Front Psychiatry. 2022 Aug 3;13:956120. doi: 10.3389/fpsyt.2022.956120. eCollection 2022.
Front Psychiatry. 2022.
PMID: 35990071
Free PMC article.